1 / 4

Imatinib Drug Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The global imatinib drug market is estimated to grow at a CAGR of around 4% during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of cancer and an increase in awareness programs towards cancer by government and private organizations.

mansi3210
Download Presentation

Imatinib Drug Market Growth, Size, Share, Industry Report and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Imatinib Drug Market, Size, Share, Analysis Report & Forecast to 2025 Request a Free Sample of our Imatinib Drug Market: https://www.omrglobal.com/request- sample/imatinib-drug-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the generic version of Novartis Pharmaceuticals Corp's Gleevec tablets 100mg and 400 mg. A full Report of Imatinib Drug Market is Available at: https://www.omrglobal.com/industry- reports/imatinib-drug-market In October 2018, Dr. Reddy’s Laboratories, Ltd. announced the launch of its Imatinib Mesylate Tablets, USP, a therapeutic equivalent generic version Gleevec tablets in the United States market for the treatment of different types of cancer. Imatinib Mesylate is a US FDA approved drug for commercial sale in the US which is expected to boost the imatinib market in the country. Imatinib Mesylate tablets are available in two different strengths i.e. 100 mg and 400 mg. Request a Free Sample of our Imatinib Drug Market: https://www.omrglobal.com/request- sample/imatinib-drug-market In September 2017, Mylan N.V. announced the US launch of Imatinib Mesylate Tablets in 100 mg and 400 mg generic version. Mylan received final approval from the U.S Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product. Imatinib Mesylate tablets can be used for multiple indications including Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES) and aggressive systemic mastocytosis (ASM). Imatinib Drug Market Segmentation By Drug Form •Tablet •Capsule By Application •Blood Cancer (Leukemia and Other Blood Cancers) •Gastrointestinal Stromal Tumors (GIST) •Skin Tumors (Dermatofibrosarcoma Protuberans) •Other Tumors (Systemic Mastocytosis) Imatinib Drug Market – Segment by Region North America •US •Canada

  3. Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World Company Profiles •Apotex Inc. •Cipla, Inc. •Dr. Reddy’s Laboratory, Ltd. •Glenmark Pharmaceutical, Ltd. •Lupin, Ltd. •Mylan N.V. •Novartis AG •Sun Pharmaceutical Industries, Ltd. •Teva Pharmaceutical Industry, Ltd. For https://www.omrglobal.com/report-customization/imatinib-drug-market More Customized Data, Request for Report Customization @ About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari

  4. Email: info@omrglobal.com Contact no: +91 7803040404

More Related